Price$11.37+3.04 (+36.49%)
2026-01-292026-05-04
News · 26 weeks67+500%
2026-04-192026-10-11
Mix3390d
- SEC Filings25(76%)
- Insider4(12%)
- Other3(9%)
- Dividends1(3%)
Latest news
25 items- SECSEC Form DEFA14A filed by Ekso Bionics Holdings Inc.DEFA14A - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form 8-K filed by Ekso Bionics Holdings Inc.8-K - ChronoScale Holdings Corp (0001549084) (Filer)
- PRChronoScale Reports Fiscal First Quarter 2027 ResultsMENLO PARK, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- ChronoScale Holdings Corporation (NASDAQ:CHRN) ("ChronoScale" or the "Company"), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, reported financial results for the fiscal first quarter ended August 31, 2026. Following the business combination completed on May 5, 2026, the Company classified its legacy Ekso Bionics business ("Legacy Ekso Business") as held for sale and reported its results in discontinued operations in accordance with U.S. generally accepted accounting principles ("GAAP"). Accordingly, Legacy Ekso Business’ results are excluded from the Company’s continuing operation
- SECSEC Form 10-Q filed by Ekso Bionics Holdings Inc.10-Q - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form EFFECT filed by Ekso Bionics Holdings Inc.EFFECT - ChronoScale Holdings Corp (0001549084) (Filer)
- INSIDERSEC Form 4 filed by Ekso Bionics Holdings Inc.4 - ChronoScale Holdings Corp (0001549084) (Issuer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form 8-K filed by Ekso Bionics Holdings Inc.8-K - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 POS filed by Ekso Bionics Holdings Inc.S-8 POS - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-3 filed by Ekso Bionics Holdings Inc.S-3 - ChronoScale Holdings Corp (0001549084) (Filer)
- SECEkso Bionics Holdings Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ChronoScale Holdings Corp (0001549084) (Filer)
- PRChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business UnitExpanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 billion by calendar Q3 2027ChronoScale completes previously disclosed sale of Ekso Bionics business unit MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- ChronoScale Holdings Corporation (NASDAQ:CHRN) ("ChronoScale" or the "Company"), an accelerated compute platform purpose-built to support demanding artificial intelligence (AI) workloads, today announced a significant expansion of an existing customer agreement and a separate agreement with a new customer, that increases the scale of its
- SECSEC Form DEF 14A filed by Ekso Bionics Holdings Inc.DEF 14A - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form DEFA14A filed by Ekso Bionics Holdings Inc.DEFA14A - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form PRER14A filed by Ekso Bionics Holdings Inc.PRER14A - ChronoScale Holdings Corp (0001549084) (Filer)
- SECEkso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - ChronoScale Holdings Corp (0001549084) (Filer)
EKSO FAQ
5 questionsWhat does Ekso Bionics Holdings Inc. do?
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock...Where does EKSO stock trade?
Ekso Bionics Holdings Inc. (EKSO) is listed on NASDAQ.What sector and industry is EKSO in?
Ekso Bionics Holdings Inc. operates in the Industrials sector, Industrial Machinery/Components industry.What companies are similar to EKSO?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), DHR (Danaher Corporation). Compare EKSO side-by-side with any of them on Quantisnow.How can I track EKSO on Quantisnow?
Quantisnow aggregates Ekso Bionics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EKSO to receive live email and push alerts on every new disclosure.